gland pharma glp-1 manufacturing capacity Q4 net profit slips 3% as US sales moderate; focus shifts to complex injectables, CDMO growth GLP-1 Receptor Agonist Market Growth
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20













/assets/production/practices/84c667cd75c703cfc49e2c00a43155eab79bfbef/images/2756782.jpg)











